To what extent does a single dose of Benadryl (diphenhydramine) prolong the QT interval?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benadryl's Effect on QT Interval Prolongation

A single dose of Benadryl (diphenhydramine) causes moderate QT prolongation, typically in the range of 30-40 milliseconds, but rarely reaches clinically dangerous levels with standard dosing in healthy individuals. 1, 2, 3

Mechanism and Extent of QT Prolongation

Diphenhydramine affects cardiac conduction through:

  • Inhibition of fast sodium channels
  • At higher concentrations, inhibition of repolarizing potassium channels, which extends the cardiac action potential and prolongs the QT interval 2

Research findings on QT prolongation with diphenhydramine:

  • In overdose cases, QTc duration was significantly longer compared to control subjects (453 ± 43 ms vs 416 ± 35 ms) 3
  • The effect is dose-dependent, with critical toxicity threshold around 1.0 g 2
  • Standard therapeutic doses typically cause less pronounced effects than what is seen in overdose situations

Risk Factors for Enhanced QT Prolongation

Certain patient factors significantly increase the risk of diphenhydramine-induced QT prolongation:

  • Female gender
  • Advanced age (>65 years)
  • Pre-existing cardiac disease
  • Renal dysfunction (particularly important as diphenhydramine was associated with QT prolongation in dialysis patients) 2
  • Electrolyte abnormalities, especially hypokalemia and hypomagnesemia 1
  • Concomitant use of other QT-prolonging medications 1, 4

Clinical Significance and Monitoring

Despite causing QT prolongation, diphenhydramine has a relatively favorable safety profile compared to some other antihistamines:

  • Torsades de pointes is rare with diphenhydramine at therapeutic doses 3
  • Even in overdose cases studied, none of the patients experienced torsades de pointes despite QT prolongation 3
  • The risk increases substantially with co-administration of other QT-prolonging drugs 4

Important Clinical Considerations

  • ECG monitoring should be considered when administering diphenhydramine to high-risk patients 1
  • Maintain serum potassium in the high-normal range (4.5-5 mmol/L) in at-risk patients 1
  • Use Fridericia's formula (QT/RR^1/3) for QTc calculation, especially with heart rates >80 bpm, as it is more accurate than Bazett's formula 1
  • Be particularly cautious with diphenhydramine in emergency settings, where it is among the most commonly prescribed QT-prolonging medications (along with azithromycin and ondansetron) 4

Risk Assessment Guidelines

QTc interval risk categories to consider when evaluating the impact of diphenhydramine:

  • High-risk: >500 ms
  • Intermediate-risk: 450-499 ms (males) or 470-499 ms (females)
  • Low-risk: <450 ms (males) or <470 ms (females) 1

Common Pitfalls to Avoid

  • Failing to recognize drug interactions with other QT-prolonging medications
  • Overlooking electrolyte abnormalities that can potentiate QT prolongation
  • Using Bazett's formula at high heart rates (overestimates QT prolongation)
  • Not considering patient-specific risk factors that may enhance QT prolongation 1

References

Guideline

Medication-Induced QT Prolongation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Use of QT-prolonging medications in US emergency departments, 1995-2009.

Pharmacoepidemiology and drug safety, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.